168 related articles for article (PubMed ID: 20042571)
1. Mycolactone suppresses T cell responsiveness by altering both early signaling and posttranslational events.
Boulkroun S; Guenin-Macé L; Thoulouze MI; Monot M; Merckx A; Langsley G; Bismuth G; Di Bartolo V; Demangel C
J Immunol; 2010 Feb; 184(3):1436-44. PubMed ID: 20042571
[TBL] [Abstract][Full Text] [Related]
2. The inhibitory action of Mycobacterium ulcerans soluble factor on monocyte/T cell cytokine production and NF-kappa B function.
Pahlevan AA; Wright DJ; Andrews C; George KM; Small PL; Foxwell BM
J Immunol; 1999 Oct; 163(7):3928-35. PubMed ID: 10490994
[TBL] [Abstract][Full Text] [Related]
3. Selective suppression of dendritic cell functions by Mycobacterium ulcerans toxin mycolactone.
Coutanceau E; Decalf J; Martino A; Babon A; Winter N; Cole ST; Albert ML; Demangel C
J Exp Med; 2007 Jun; 204(6):1395-403. PubMed ID: 17517970
[TBL] [Abstract][Full Text] [Related]
4. Mycolactone diffuses from Mycobacterium ulcerans-infected tissues and targets mononuclear cells in peripheral blood and lymphoid organs.
Hong H; Coutanceau E; Leclerc M; Caleechurn L; Leadlay PF; Demangel C
PLoS Negl Trop Dis; 2008; 2(10):e325. PubMed ID: 18941518
[TBL] [Abstract][Full Text] [Related]
5. Modulation of the host immune response by a transient intracellular stage of Mycobacterium ulcerans: the contribution of endogenous mycolactone toxin.
Coutanceau E; Marsollier L; Brosch R; Perret E; Goossens P; Tanguy M; Cole ST; Small PL; Demangel C
Cell Microbiol; 2005 Aug; 7(8):1187-96. PubMed ID: 16008585
[TBL] [Abstract][Full Text] [Related]
6. Targeting of CD45 protein tyrosine phosphatase activity to lipid microdomains on the T cell surface inhibits TCR signaling.
He X; Woodford-Thomas TA; Johnson KG; Shah DD; Thomas ML
Eur J Immunol; 2002 Sep; 32(9):2578-87. PubMed ID: 12207342
[TBL] [Abstract][Full Text] [Related]
7. IFN-gamma-dependent activation of macrophages during experimental infections by Mycobacterium ulcerans is impaired by the toxin mycolactone.
Torrado E; Fraga AG; Logarinho E; Martins TG; Carmona JA; Gama JB; Carvalho MA; Proença F; Castro AG; Pedrosa J
J Immunol; 2010 Jan; 184(2):947-55. PubMed ID: 20008288
[TBL] [Abstract][Full Text] [Related]
8. Immunosuppressive signature of cutaneous Mycobacterium ulcerans infection in the peripheral blood of patients with buruli ulcer disease.
Phillips R; Sarfo FS; Guenin-Macé L; Decalf J; Wansbrough-Jones M; Albert ML; Demangel C
J Infect Dis; 2009 Dec; 200(11):1675-84. PubMed ID: 19863437
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of p56(lck) tyrosine kinase by isothiazolones.
Trevillyan JM; Chiou XG; Ballaron SJ; Tang QM; Buko A; Sheets MP; Smith ML; Putman CB; Wiedeman P; Tu N; Madar D; Smith HT; Gubbins EJ; Warrior UP; Chen YW; Mollison KW; Faltynek CR; Djurić SW
Arch Biochem Biophys; 1999 Apr; 364(1):19-29. PubMed ID: 10087161
[TBL] [Abstract][Full Text] [Related]
10. The Src-homology domain 2-bearing protein tyrosine phosphatase-1 inhibits antigen receptor-induced apoptosis of activated peripheral T cells.
Zhang J; Somani AK; Watt S; Mills GB; Siminovitch KA
J Immunol; 1999 Jun; 162(11):6359-67. PubMed ID: 10352248
[TBL] [Abstract][Full Text] [Related]
11. Inactivation of lck and loss of TCR-mediated signaling upon persistent engagement with complexes of peptide:MHC molecules.
Lee JE; Cossoy MB; Chau LA; Singh B; Madrenas J
J Immunol; 1997 Jul; 159(1):61-9. PubMed ID: 9200439
[TBL] [Abstract][Full Text] [Related]
12. Pleiotropic molecular effects of the Mycobacterium ulcerans virulence factor mycolactone underlying the cell death and immunosuppression seen in Buruli ulcer.
Hall B; Simmonds R
Biochem Soc Trans; 2014 Feb; 42(1):177-83. PubMed ID: 24450648
[TBL] [Abstract][Full Text] [Related]
13. HIV-1 down-regulates CD4 costimulation of TCR/CD3-directed tyrosine phosphorylation through CD4/p56lck dissociation.
Kanner SB; Haffar OK
J Immunol; 1995 Mar; 154(6):2996-3005. PubMed ID: 7876562
[TBL] [Abstract][Full Text] [Related]
14. A CD28-associated signaling pathway leading to cytokine gene transcription and T cell proliferation without TCR engagement.
Siefken R; Klein-Hessling S; Serfling E; Kurrle R; Schwinzer R
J Immunol; 1998 Aug; 161(4):1645-51. PubMed ID: 9712026
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory effects of rosmarinic acid on Lck SH2 domain binding to a synthetic phosphopeptide.
Ahn SC; Oh WK; Kim BY; Kang DO; Kim MS; Heo GY; Ahn JS
Planta Med; 2003 Jul; 69(7):642-6. PubMed ID: 12898421
[TBL] [Abstract][Full Text] [Related]
16. Mycolactone inhibits monocyte cytokine production by a posttranscriptional mechanism.
Simmonds RE; Lali FV; Smallie T; Small PL; Foxwell BM
J Immunol; 2009 Feb; 182(4):2194-202. PubMed ID: 19201873
[TBL] [Abstract][Full Text] [Related]
17. Involvement of tyrosine kinase p56/Lck in apoptosis induction by anticancer drugs.
Gruber C; Henkel M; Budach W; Belka C; Jendrossek V
Biochem Pharmacol; 2004 May; 67(10):1859-72. PubMed ID: 15130763
[TBL] [Abstract][Full Text] [Related]
18. Complement regulatory protein Crry/p65-mediated signaling in T lymphocytes: role of its cytoplasmic domain and partitioning into lipid rafts.
Jiménez-Periañez A; Ojeda G; Criado G; Sánchez A; Pini E; Madrenas J; Rojo JM; Portolés P
J Leukoc Biol; 2005 Dec; 78(6):1386-96. PubMed ID: 16301324
[TBL] [Abstract][Full Text] [Related]
19. Activation of type I protein kinase A during receptor-mediated human T lymphocyte activation.
Laxminarayana D; Kammer GM
J Immunol; 1996 Jan; 156(2):497-506. PubMed ID: 8543799
[TBL] [Abstract][Full Text] [Related]
20. Mycobacterium ulcerans toxic macrolide, mycolactone modulates the host immune response and cellular location of M. ulcerans in vitro and in vivo.
Adusumilli S; Mve-Obiang A; Sparer T; Meyers W; Hayman J; Small PL
Cell Microbiol; 2005 Sep; 7(9):1295-304. PubMed ID: 16098217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
